Gail M Farfel - Net Worth and Insider Trading
Gail M Farfel Net Worth
The estimated net worth of Gail M Farfel is at least $145,686 dollars as of 2024-11-28. Gail M Farfel is the EVP/Chief Development Officer of Zogenix Inc and owns about 5,048 shares of Zogenix Inc (ZGNX) stock worth over $134,681. Gail M Farfel is the Director of Durect Corp and owns about 10,000 shares of Durect Corp (DRRX) stock worth over $9,125. Gail M Farfel is also the CEO of ProMIS Neurosciences Inc and owns about 2,000 shares of ProMIS Neurosciences Inc (PMN) stock worth over $1,880. Besides these, Gail M Farfel also holds Marinus Pharmaceuticals Inc (MRNS) . Details can be seen in Gail M Farfel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gail M Farfel has not made any transactions after 2022-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gail M Farfel
Gail M Farfel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gail M Farfel owns 5 companies in total, including Avrobio Inc (AVRO) , Zogenix Inc (ZGNX) , and Durect Corp (DRRX) among others .
Click here to see the complete history of Gail M Farfel’s form 4 insider trades.
Insider Ownership Summary of Gail M Farfel
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AVRO | Avrobio Inc | 2020-10-19 | director |
ZGNX | Zogenix Inc | 2020-06-25 | EVP/Chief Development Officer |
DRRX | Durect Corp | 2022-05-18 | director |
2015-04-21 | Chief Clinical Dev.Regulatory | ||
2023-08-23 | director & Chief Executive Officer |
Gail M Farfel Latest Holdings Summary
Gail M Farfel currently owns a total of 4 stocks. Among these stocks, Gail M Farfel owns 5,048 shares of Zogenix Inc (ZGNX) as of May 12, 2020, with a value of $134,681 and a weighting of 92.45%. Gail M Farfel owns 10,000 shares of Durect Corp (DRRX) as of May 18, 2022, with a value of $9,125 and a weighting of 6.26%. Gail M Farfel also owns 2,000 shares of ProMIS Neurosciences Inc (PMN) as of December 14, 2022, with a value of $1,880 and a weighting of 1.29%. The other 1 stocks Marinus Pharmaceuticals Inc (MRNS) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Gail M Farfel
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZGNX | Zogenix Inc | 2020-05-12 | 5,048 | 26.68 | 134,681 |
DRRX | Durect Corp | 2022-05-18 | 10,000 | 0.91 | 9,125 |
PMN | ProMIS Neurosciences Inc | 2022-12-14 | 2,000 | 0.94 | 1,880 |
MRNS | Marinus Pharmaceuticals Inc | 2015-04-21 | 0 | 0.32 | 0 |
Holding Weightings of Gail M Farfel
Gail M Farfel Form 4 Trading Tracker
According to the SEC Form 4 filings, Gail M Farfel has made a total of 1 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zogenix Inc is the sale of 2,573 shares on May 12, 2020, which brought Gail M Farfel around $72,584.
According to the SEC Form 4 filings, Gail M Farfel has made a total of 4 transactions in Durect Corp (DRRX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Durect Corp is the acquisition of 5,521 shares on May 18, 2022, which cost Gail M Farfel around $22,084.
According to the SEC Form 4 filings, Gail M Farfel has made a total of 2 transactions in ProMIS Neurosciences Inc (PMN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ProMIS Neurosciences Inc is the acquisition of 1,000 shares on December 14, 2022, which cost Gail M Farfel around $4,940.
More details on Gail M Farfel's insider transactions can be found in the Insider Trading History of Gail M Farfel table.Insider Trading History of Gail M Farfel
- 1
Gail M Farfel Trading Performance
GuruFocus tracks the stock performance after each of Gail M Farfel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gail M Farfel is 52.49%. GuruFocus also compares Gail M Farfel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gail M Farfel within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gail M Farfel's insider trading performs compared to the benchmark.
Performance of Gail M Farfel
Gail M Farfel Ownership Network
Gail M Farfel Owned Company Details
What does Avrobio Inc do?
Who are the key executives at Avrobio Inc?
Gail M Farfel is the director of Avrobio Inc. Other key executives at Avrobio Inc include Chief Technology Officer Azadeh Golipour , Chief Medical Officer Essra Ridha , and Chief Scientific Officer Christopher Mason .
Avrobio Inc (AVRO) Insider Trades Summary
Over the past 18 months, Gail M Farfel made no insider transaction in Avrobio Inc (AVRO). Other recent insider transactions involving Avrobio Inc (AVRO) include a net purchase of 766,635 shares made by Braden Michael Leonard ,
In summary, during the past 3 months, insiders sold 0 shares of Avrobio Inc (AVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avrobio Inc (AVRO) were sold and 63,886 shares were bought by its insiders, resulting in a net purchase of 63,886 shares.
Avrobio Inc (AVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avrobio Inc Insider Transactions
Gail M Farfel Mailing Address
Above is the net worth, insider trading, and ownership report for Gail M Farfel. You might contact Gail M Farfel via mailing address: 142 Temple Street, Suite 205, New Haven Ct 06510.